Folgen
Veronika Blum
Veronika Blum
Tumor Zentrum Aarau
Bestätigte E-Mail-Adresse bei tumor-zentrum.ch - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Deregulated expression of Kruppel-like factors in acute myeloid leukemia
M Humbert, V Halter, D Shan, J Laedrach, EO Leibundgut, GM Baerlocher, ...
Leukemia research 35 (7), 909-913, 2011
722011
Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases
V Blum, B Müller, S Hofer, E Pardo, K Zeidler, J Diebold, K Strobel, ...
European Journal of Dermatology 28, 78-81, 2018
552018
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases
JK Dermawan, EM Azzato, SD Billings, KJ Fritchie, S Aubert, A Bahrami, ...
Modern Pathology 34 (12), 2211-2221, 2021
332021
Patterns of care for patients with metastatic bone disease in solid tumors: a cross-sectional study from Switzerland (SAKK 95/16)
M Mark, B Thürlimann, K Ribi, C Schär, D Dietrich, R Cathomas, ...
Journal of bone oncology 21, 100273, 2020
142020
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022
C Rothermundt, D Andreou, JY Blay, T Brodowicz, IME Desar, P Dileo, ...
European Journal of Cancer 180, 158-179, 2023
122023
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
S Schmid, LA Mauti, A Friedlaender, V Blum, SI Rothschild, H Bouchaab, ...
Cancer Immunology, Immunotherapy 69, 1605-1613, 2020
82020
Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML
V Blum, AD Heini, U Novak, BM Taleghani, GM Baerlocher, K Leibundgut, ...
Bone marrow transplantation 52 (5), 786-788, 2017
72017
1540P Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
NM Zellweger, S Schmid, M Bertschinger, C Waibel, FWF Cerciello, ...
Annals of Oncology 33, S1251, 2022
52022
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report
V Blum, V Andrei, B Ameline, S Hofer, B Fuchs, K Strobel, A Allemann, ...
Frontiers in Oncology 12, 1086677, 2022
42022
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents–a real-world cross-sectional study from Switzerland (SAKK …
K Ribi, B Thürlimann, C Schär, D Dietrich, R Cathomas, U Zürrer-Härdi, ...
BMC cancer 21, 1-9, 2021
32021
66P Real-world data of first-line chemo-immunotherapy for patients with extensive stage SCLC: A multicentre experience from Switzerland and the UK
L Moliner, NM Zellweger, SM Schmidt, C Waibel, PR Froesch, P Häuptle, ...
Immuno-Oncology and Technology 16, 2022
12022
Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment
S Hofer, L Hentschel, S Richter, V Blum, M Kramer, B Kasper, C Riese, ...
Cancers 15 (4), 1233, 2023
2023
«Less is more» bei medikamentösen Tumortherapien
GO Hecz M, Aebi S, Müller B, Zander T, Riklin C, Winterhalder R, Weiler D ...
Swiss Med Forum, 2023
2023
Mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report
V Blum, V Andrei, B Ameline, S Hofer, B Fuchs, K Strobel, A Allemann, ...
2022
Combined chemo-immunotherapy as first-line treatment in patients with advanced/metastatic small cell lung cancer (" extensive disease")-a real-world, multicenter analysis
N Zellweger, S Schmid, M Bertschinger, C Waibel, F Cerciello, P Froesch, ...
ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 2), 207-207, 2022
2022
Patient-reported outcomes in patients with metastatic bone disease from solid tumors treated with bone-targeted agents: a real-world study (SAKK 95/16)
K Ribi, B Thurlimann, C Schar, D Dietrich, R Cathomas, U Zurrer-Hardi, ...
SWISS MEDICAL WEEKLY, 27S-28S, 2020
2020
P2. 12-21 Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort
L Mauti, S Schmid, I Demmer, A Friedlaender, V Blum, S Rothschild, ...
Journal of Thoracic Oncology 14 (10), S821-S822, 2019
2019
The Role of Krüppel-like Factor 6 (KLF6) in Neutrophil Differentiation of AML Cells
V Blum-Halter
[Verlag nicht ermittelbar] $ c2012., 2012
2012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–18